Type 2 Diabetes + Fatty Liver: MASH Trials That Fit Both
Trials targeting the overlap of type 2 diabetes and MASH/MASLD: GLP-1 outcomes studies, FGF21 analogs, and how dual eligibility expands your options.
Trials targeting the overlap of type 2 diabetes and MASH/MASLD: GLP-1 outcomes studies, FGF21 analogs, and how dual eligibility expands your options.